Coronary Artery Disease

Digital Education Hubs

CME / CE Virtual Symposium
Cardiovascular Disease
Clinical Brief
Clinical Brief: Antithrombotic and Antiplatelet Therapy in the Cardiometabolic Patient
CME/CE Credits: 1.0 hrs
Cardiovascular Disease
Virtual Symposium
Preventing Cardiovascular Events in High-Risk Diabetes Patients with CAD: New Insights and Developments
CME/CE Credits: 1.0 hrs
Expert Highlights and Perspectives
Lawrence A. Leiter, MD, FRCPC, FACP, FACE, FAHA, FACC

Interview #1

Diabetes and the Increase Risk of Atherothrombotic Events

Deepak Bhatt,
MD

P. Gabriel Steg,
MD

Lawrence A. Leiter,
MD, FRCPC, FACP, FACE, FAHA, FACC
  • Increased platelet aggregation & activation in diabetes patients
  • Reduced responsiveness to commonly-used antiplatelet agents
  • The role of antiplatelet therapy in patients with diabetes
  • Summary and contextualization of THEMIS & THEMIS-PCI trials
Lawrence A. Leiter, MD, FRCPC, FACP, FACE, FAHA, FACC

Interview #2

How Do These Advances Fit in With Existing Therapies and Other Updates in Secondary Prevention in Diabetes Patients?

Deepak Bhatt,
MD

P. Gabriel Steg,
MD

Lawrence A. Leiter,
MD, FRCPC, FACP, FACE, FAHA, FACC
  • Going beyond glucose in diabetes
  • Multifactorial risk reduction
  • SGLT-2 inhibitors & recent updates
Lawrence A. Leiter, MD, FRCPC, FACP, FACE, FAHA, FACC

Interview #3

Advances in Dual Pathway Inhibition in Diabetes Patients

Deepak Bhatt,
MD

P. Gabriel Steg,
MD

Lawrence A. Leiter,
MD, FRCPC, FACP, FACE, FAHA, FACC
  • Overlap between dual antiplatelet therapy (DAPT) and dual pathway inhibition (DPI)
  • Which form of double antithrombotic agent/regimen should be used in patient
  • Integrating and interpreting the data from COMPASS and THEMIS/THEMIS-PCI
Subscribe to "The Monthly Beat" Newsletter

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.

Copyright © 2021, Cardiometabolic Health Congress. All Rights Reserved.

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.